The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tisotumab vedotin in 2L/3L recurrent or metastatic cervical cancer: Subsequent therapy data from ENGOT-cx12/GOG-3057/innovaTV 301.
 
Luis Manso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Tesaro
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; Novartis; Roche/Genentech; Tesaro
 
Ignace Vergote
Consulting or Advisory Role - Agenus; Akeso Biopharma; AstraZeneca; Bristol Myers Squibb; Deciphera; Eisai; Elevar Therapeutics; Exelixis; Genmab; GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Mersana; MSD; Novartis; Novocure; Oncoinvent; OncXerna Therapeutics; Regeneron; Roche; Sanofi; Seagen; Sotio; Verastem; Zentalis
Research Funding - Amgen (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genmab; Karyopharm Therapeutics; Novocure
 
Keiichi Fujiwara
Honoraria - Daiichi Sankyo; Eisai; Genmab; Takeda
Consulting or Advisory Role - Eisai; Genmab; MSD; Seagen; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Genmab (Inst); MSD (Inst); Regeneron (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genmab
 
Antoine Angelergues
No Relationships to Disclose
 
Michal Zikan
No Relationships to Disclose
 
Scott Jordan
Consulting or Advisory Role - Eisai
Speakers' Bureau - Seagen
Travel, Accommodations, Expenses - Intuitive Surgical
 
Jung-Yun Lee
Consulting or Advisory Role - Eisai; GI Innovation
Speakers' Bureau - AstraZeneca; MSD; Roche; Takeda
 
Lisa Barraclough
No Relationships to Disclose
 
Fernando Cotait Maluf
Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme
 
Domenica Lorusso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo/Lilly; Genmab; GlaxoSmithKline; Immunogen; MSD; Novartis; Novocure; Oncoinvest; PharmaMar; Seagen; Sutro Biopharma
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; ImmunoGen; MSD; Seagen
Research Funding - Alkermes (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Incyte (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Pharma& (Inst); PharmaMar (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Menarini
(OPTIONAL) Uncompensated Relationships - ENGOT; Gynecological Cancer InterGroup; MITO
 
Kan Yonemori
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Eisai; Fujifilm; Lilly Japan; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Chugai Pharma; Eisai; Henlius; Novartis; OncXerna Therapeutics; Ono Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); Genmab (Inst); Haihe Pharmaceutical (Inst); Kyowa Hakko Kirrin (Inst); Lilly (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
 
Christine Gennigens
Honoraria - AstraZeneca; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Ipsen; MSD Oncology; Pfizer; PharmaMar
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene; Eisai; GlaxoSmithKline; Ipsen; MSD Oncology
Research Funding - AstraZeneca; AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Gilead/Forty Seven (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Ipsen; MSD Oncology; Pfizer; PharmaMar
 
Antonio Gonzalez Martin
Consulting or Advisory Role - Alkermes; Amgen; AstraZeneca; Clovis Oncology; Genmab; Hedera Dx; Immunogen; Kartos Therapeutics; Macrogenics; Mersana; MSD; Novartis; Novocure; Oncoinvent; Pfizer/EMD Serono; Roche; Seagen; SOTIO; Sutro Biopharma; Takeda; Tesaro/GSK; Tubulis GmbH
Speakers' Bureau - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro/GSK
Research Funding - Roche (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; PharmaMar; Roche; Tesaro/GSK
 
Florian Heitz
Honoraria - AstraZeneca; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Novocure; PharmaMar; Roche
Research Funding - Amedes (Inst); AstraZeneca (Inst)
 
Anneke M. Westermann
No Relationships to Disclose
 
Allan Covens
Research Funding - GlaxoSmithKline
 
Elizabeth Whalley
Employment - Pfizer; Pfizer (I); Seagen; Seagen (I)
Stock and Other Ownership Interests - Pfizer; Pfizer; Seagen; Seagen
 
Yiyi Chen
Employment - Pfizer; Ultragenyx Pharmaceuticals (I)
Stock and Other Ownership Interests - Ultragenyx Pharmaceuticals (I)
 
Ibrahima Soumaoro
Employment - Genmab
Stock and Other Ownership Interests - Bristol-Myers Squibb; Genmab
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genmab
 
Leslie M. Randall
Honoraria - BluPrint Oncology; Curio Science; PER
Consulting or Advisory Role - AADi; AstraZeneca; Caris Life Sciences; Clovis Oncology; Eisai; Genentech/Roche; GOG Foundation; Immunogen; Merck; Mersana; Myriad Genetics; Novocure; On Target Laboratories; Rubius Therapeutics; Seagen
Speakers' Bureau - AstraZeneca; AstraZeneca; Genmab/Seagen
Research Funding - Acrivon Therapeutics (Inst); Adaptimmune (Inst); Akeso Biopharma (Inst); GEICO (Inst); GOG Foundation (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mersana (Inst); Regeneron (Inst); Zentalis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genmab; GOG Foundation; Seagen